Home›Companies›Healthcare›MaxQ Medical

MaxQ Medical Inc.

Develops a prostate imaging and treatment system for urologists.

Updated Nov 9, 2026·Latest SEC filing Aug 19, 2026·Suggest an edit

About MaxQ Medical

MaxQ Medical is a private company based in Sunnyvale, California, incorporated in 2023 in Delaware. It has reported $31,579,997 raised in two offerings on Form D since June 2024. Its chief executive is Amir Tehrani.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 22, 2026Aug 19, 2026$31,529,997fully sold11$2.8MEquityRule 506(b), 4a5Form D ↗
Apr 3, 2024Jun 18, 2024$50,000fully sold17$2,941EquityRule 506(b), 4a5Form D ↗
Total, two offerings$31,579,997

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on MaxQ Medical's Form D filed Aug 19, 2026.

Amir Abolfathi
Amir Abolfathi
Executive Chairman
Also a director at BRIUS and R3 Vascular and an independent board member at Ventaris Surgical.
Brian Smith
Brian Smith
Director
Also a director at Alleviant Medical and SpectraWAVE and a founder and managing director, S3 ventures at VahatiCor.
JI
John Irwin III
Director
Also an executive officer and director at Brookside Capital.
AT
Amir Tehrani
CEO and director
DR
Dean Riskas
Director

Earlier filings also listed Priscilla Babb (director, last listed Jun 2024), Paul Khuri-Yakub (executive officer, last listed Jun 2024) and Andre Khoury-Yacoub (director, last listed Jun 2024).

Sources

  1. SECMaxQ Medical Inc. filing history
  2. PressMaxQ Medical Series A announcement